Pineoblastoma: Clinical Trials

9 trials for Pineoblastoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 recruiting, 1 active not recruiting, 1 withdrawn. 9 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 19Completed 4, Recruiting 3, Active not recruiting 1, Withdrawn 1
Phase 21Completed 1

Follow Pineoblastoma: new trials by email Literature Review of Pineoblastoma trials Research Report on Pineoblastoma

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
B7-H3.CD28Z.CART in CNS Neoplasms
B7-H3.CD28Z.CART, Fludarabine, Cyclophosphamide - Central Nervous System Neoplasms, Brain Tumor
Phase 1RecruitingRobbie Majzner702026-09-012026-09-03
GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
GPC2-CAR T cells, Fludarabine, Cyclophosphamide - Medulloblastoma, Central Nervous System Embryonal Tumor
Phase 1RecruitingStanford University182025-08-282026-10-09
Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)
Multi-tumor antigen specific cytotoxic T lymphocytes (TSA-T) directed against proteogenomically determined personalized tumor-specific antigens (TSA), Group A Standard-of-Care Backbone Therapy, Group B Salvage Backbone Therapy - Medulloblastoma, Childhood, Atypical Teratoid/Rhabdoid Tumor of CNS
Phase 1RecruitingChildren's National Research Institute122024-09-202026-10-13
StrataXRT in Preventing Radiation Dermatitis in Pediatric Patients Undergoing Radiation Therapy to the Brain or Spinal Cord
Placebo Administration, Questionnaire Administration, Wound Dressing Material - Central Nervous System Sarcoma, Ependymoma
Phase 1WithdrawnM.D. Anderson Cancer Center2019-08-192024-10-09
EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors
EGFR806-specific chimeric antigen receptor (CAR) T cell - Central Nervous System Tumor, Pediatric, Glioma
Phase 1CompletedSeattle Children's Hospital112019-03-192025-12-17
HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors
HER2-specific chimeric antigen receptor (CAR) T cell - Central Nervous System Tumor, Pediatric, Glioma
Phase 1Active not recruitingSeattle Children's Hospital102018-07-262025-12-17
SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
Gemcitabine, ribociclib, sonidegib - Anaplastic Astrocytoma, Anaplastic Ependymoma
Phase 1CompletedSt. Jude Children's Research Hospital682018-03-052024-05-31
Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Adavosertib, Irinotecan Hydrochloride - Central Nervous System Embryonal Tumor With Rhabdoid Features, Central Nervous System Embryonal Tumor, Not Otherwise Specified
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)762014-03-282023-09-26
Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System
3-Dimensional Conformal Radiation Therapy, Carboplatin, Cisplatin - Medulloblastoma, Pineoblastoma
Phase 1CompletedNational Cancer Institute (NCI)332009-02-252022-01-13

Narrower conditions

Medulloblastoma (9)  ·  Pinealoma (9)  ·  Neuroectodermal Tumors, Primitive (7)  ·  Central Nervous System Neoplasms (6)  ·  Ependymoma (6)  ·  Rhabdoid Tumor (6)  ·  Brain Neoplasms (5)  ·  Glioma (4)  ·  Choroid Plexus Carcinoma (3)  ·  Neoplasms, Germ Cell and Embryonal (3)  ·  Astrocytoma (1)  ·  Glioblastoma (1)  ·  Lymphoma, Follicular (1)  ·  Meningeal Neoplasms (1)  ·  Meningioma (1)

Broader conditions

Brain Diseases (9)  ·  Central Nervous System Diseases (9)  ·  Neoplasms by Histologic Type (9)  ·  Neoplasms by Site (9)  ·  Neoplasms, Glandular and Epithelial (9)  ·  Neoplasms, Nerve Tissue (9)  ·  Nervous System Diseases (9)  ·  Nervous System Neoplasms (9)  ·  Neuroectodermal Tumors (9)  ·  Neoplasms (8)  ·  Neoplasms, Neuroepithelial (8)  ·  Neoplasms, Complex and Mixed (6)  ·  Neoplasms, Germ Cell and Embryonal (6)  ·  Glioma (5)  ·  Brain Neoplasms (4)

Interventions

Cyclophosphamide (3)  ·  Automobiles (2)  ·  fludarabine (2)  ·  1,2-diaminocyclohexaneplatinum II citrate (1)  ·  Bandages (1)  ·  Carboplatin (1)  ·  Cisplatin (1)  ·  Filgrastim (1)  ·  Gemcitabine (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Irinotecan (1)  ·  Isotretinoin (1)  ·  Peripheral Blood Stem Cell Transplantation (1)  ·  Platinum (1)  ·  Radiotherapy, Conformal (1)

Sponsors

National Cancer Institute (NCI) (2)  ·  Seattle Children's Hospital (2)  ·  Children's National Research Institute (1)  ·  M.D. Anderson Cancer Center (1)  ·  Robbie Majzner (1)  ·  St. Jude Children's Research Hospital (1)  ·  Stanford University (1)

Countries

United States (9)  ·  Canada (1)

Top investigators

Brian Rood, MD (1)  ·  Giles W. Robinson, MD (1)  ·  Juliane Gust, MD, PhD (1)  ·  Katherine Ryan, DO (1)  ·  Kristina A Cole (1)  ·  Rebecca Ronsley, MD (1)  ·  Sarah E Leary (1)  ·  Susan Chi (1)  ·  Susan L McGovern (1)

Results publications

PMID 34253928, PMID 37640679

NIH funding

U01CA081457 (1), UM1CA081457 (1), UM1CA097452 (1)